Press Releases

Date Title and Summary Additional Formats
Toggle Summary Wendy Cameron Elected to Mylan Laboratories' Board of Directors; Board is Increased to 11
Wendy Cameron Elected to Mylan Laboratories' Board of Directors; Board is Increased to 11 PITTSBURGH, May 8, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. announced today that it has named Wendy Cameron, 42, to its Board of Directors, effective May 2, 2002. Ms.
View HTML
Toggle Summary Mylan Establishes the Mylan Laboratories Charitable Foundation
Mylan Establishes the Mylan Laboratories Charitable Foundation PITTSBURGH, Pa., May 7, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) today announced that it has established the Mylan Laboratories Charitable Foundation, a 501 © (3) non-profit organization dedicated to providing support
View HTML
Toggle Summary Mylan Laboratories Inc. Announces Fiscal 2002 Fourth Quarter and Year End Earnings Release Date and Conference Call
Mylan Laboratories Inc. Announces Fiscal 2002 Fourth Quarter and Year End Earnings Release Date and Conference Call PITTSBURGH, Apr 30, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE: MYL) announced today that it will release its fiscal 2002 fourth quarter and full year financial results
View HTML
Toggle Summary Mylan Declares Regular Quarterly Cash Dividend
Mylan Declares Regular Quarterly Cash Dividend PITTSBURGH, Mar 15, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) announced today that the regular quarterly cash dividend of four cents per share will be paid on April 15, 2002 to shareholders of record March 29, 2002.
View HTML
Toggle Summary Mylan Announces Fiscal 2003 Guidance
Mylan Announces Fiscal 2003 Guidance PITTSBURGH, Mar 5, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) today is pleased to announce its fiscal 2003 guidance of $2.05 - $2.09. As previously announced, Mylan will host a conference call and Webcast today, at 10:00 AM ET.
View HTML
Toggle Summary Mylan Announces Senior Management and Board Appointments
Mylan Announces Senior Management and Board Appointments PITTSBURGH, Mar 5, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) today announced that it has named Edward J. Borkowski as Chief Financial Officer of the company. Mr. Borkowski joins Mylan from Pharmacia Corporation (NYSE:PHA)
View HTML